Dermatology

Biologics and small molecules for psoriasis: current and future progress

Luca Potestio, Nello Tommasino, Michela D’Agostino, Valeria Esposito, Giuseppe Lauletta, Antonio Portarapillo, Matteo Megna

Article Type

Review

Published

This narrative review explores new systemic therapies for psoriasis, including both approved and emerging biologics and small molecules, highlighting future directions in treatment.

Read more

Real-world analysis of IL-23 inhibitors in patients with moderate-to-severe psoriasis and early musculoskeletal symptoms

Annunziata Dattola, Nicoletta Bernardini, Jasmine Anedda, Laura Atzori, Claudio Bonifati, Pier Luigi Bruni, Domenico Giordano, Dario Graceffa, Elisa Molinelli, Gaia Moretta, Cristina Mugheddu, Annamaria Offidani, Gianluca Pagnanelli, Sabatino Pallotta, Manuela Papini, Severino Persechino, Antonio Giovanni Richetta, Ersilia Tolino, Federica Trovato, Giovanni Pellacani, Concetta Potenza

Article Type

Original Research

Published

This article aims to evaluate the effect of IL-23 inhibitors on clinical outcomes and progression of PsA in patients with moderate-to-severe psoriasis and early musculoskeletal involvement.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.

Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.